Clinical Trial Update: STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma [Phase 1]

View source ↗

Summary

A Phase 1 study of STIL101 for injection across pancreatic ductal adenocarcinoma, colorectal cancer, renal cell carcinoma, cervical cancer, and melanoma has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Colorectal Cancer
• Melanoma
• Pancreatic Ductal Adenocarcinoma
• Renal Cell Carcinoma

Drugs mentioned

• STIL101

Snippet

Sponsor: City of Hope Medical Center | Conditions: Locally Advanced Cervical Carcinoma, Locally Advanced Colorectal Carcinoma | Phase 1 | Status: WITHDRAWN